SalzerW.Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them.Perit Dial Int2005; 25: 313–19.
2.
FriedL.F., BernardiniJ., JohnstonJ.R., PirainoB.Peritonitis influences mortality in peritoneal dialysis patients.J Am Soc Nephrol1996; 7: 2176–82.
3.
MortinL.I., LiT., Van PraagghA.D., ZhangS., ZhangX.X., AlderJ.D.Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.Antimicrob Agents Chemother2007; 51: 1787–94.
4.
HermsenE.D., HovdeL.B., HotchkissJ.R., RotschaferJ.C.Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal model.Antimicrob Agents Chemother2003; 47: 3764–7.
5.
HassounA.A., CoomerR.W., Mendez-VigoL.Intraperitoneal daptomycin used to successfully treat vancomycin-resistant Enterococcus peritonitis.Perit Dial Int2009; 29: 671–3.
6.
HuenS.C., HallI., TopalJ., MahnensmithR.L., BrewsterU., Abu AlfaA.K.Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant Enterococcus peritonitis.Am J Kidney Dis2009; 54: 538–41.
7.
BahteS.K., BertramA., BurkhardtO., Martens-LobenhofferJ., GoedeckeV., Bode-BögerS.M.Therapeutic serum concentrations of daptomycin after intraperitoneal administration in patient with peritoneal dialysis-associated peritonitis.J Antimicrob Chemother2010; 65: 1312–14.
8.
De VinF., RutherfordP., FaictD.Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.Perit Dial Int2009; 29: 5–15.
